You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-small-cell lung cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Huaier Granules in Postoperative Adjuvant Therapy for Non-small

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Huaier granule
  • Control
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Oct 27, 2023

NSCLC Trial in Suzhou (Envafolimab Injection)

Recruiting
  • NSCLC
  • Envafolimab Injection
  • Suzhou, Jiangsu, China
    Northern Jiangsu People's Hospital
Oct 29, 2023

NSCLC Trial in Beijing (Pyrotinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Beijing, Beijing, China
    Peking Union Medical College
Feb 20, 2023

ALK Positive NSCLC Trial in Guangzhou (Loratinib)

Recruiting
  • ALK Positive Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial Perople's Hospital
Oct 19, 2023

Advanced Squamous Non Small Cell Lung Cancer Trial (AK112, Carboplatin, Paxlitaxel, Tislelizumab, Carboplatin, Paxlitaxel)

Not yet recruiting
  • Advanced Squamous Non Small Cell Lung Cancer
  • AK112, Carboplatin, Paxlitaxel
  • Tislelizumab, Carboplatin, Paxlitaxel
  • (no location specified)
Apr 21, 2023

Blood Samples in Patients With Non-small Cell Lung Cancer

Recruiting
  • Stage III Non-Small Cell Lung Cancer AJCC v7
  • +3 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 18, 2022

Genetic and Epigenetic Factors on Clinical Response and Toxicity

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Cisplatin injection
  • Cairo, Egypt
    Ain Shams University
Feb 16, 2023

Contribution of Fractional Exhaled Nitric Oxide asPrognostic

Not yet recruiting
  • Metastatic Non-small Cell Lung Cancer
  • Measurement of FeNO
  • Dijon, France
    Chu Dijon Bourgogne
Aug 8, 2023

PET-CT Predicting Segement Specific Lymph Nodes Metastasis

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Shanghai, China
      Shanghai Cancer Center
    Jul 23, 2023

    Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

    Not yet recruiting
    • NSCLC
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Aug 6, 2023

      NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Mar 23, 2023

      Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy Trial in Wuhan (CTV omitted or delineated)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • CTV omitted or delineated
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Sep 1, 2023

      Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +2 more
      • (no location specified)
      Jan 12, 2023

      NSCLC Trial in Guangzhou (SKB264, Pembrolizumab, Carboplatin)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University, Cancer Center
      Apr 14, 2023

      Non Squamous Non Small Cell Lung Cancer, EGFR Positive NSCLC Trial (Toripalimab plus Chemotherapy)

      Not yet recruiting
      • Non Squamous Non Small Cell Lung Cancer
      • EGFR Positive Non-small Cell Lung Cancer
      • Toripalimab plus Chemotherapy
      • (no location specified)
      Jul 28, 2023

      NSCLC Trial in Shanghai (BL-B01D1, Osimertinib Mesylate Tablets)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      May 25, 2023

      Metastatic Non Small Cell Lung Cancer Trial in Raleigh (C-TIL051)

      Not yet recruiting
      • Metastatic Non Small Cell Lung Cancer
      • C-TIL051
      • Raleigh, North Carolina
        Duke Cancer Institute
      Jan 6, 2023

      Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)

      Not yet recruiting
      • Advanced Squamous Non-Small-Cell Lung Cancer
      • (no location specified)
      Jun 11, 2023

      NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Wuhan, Hubei, China
        Qian Chu
      Aug 18, 2023

      NSCLC?EGFR Sensitive Mutation Trial in Bengbu, Changsha, Shanghai (MCLA-129: 1500mg or 2000mg IV Q2W, Befotertinib: 75 mg or 100

      Not yet recruiting
      • Non-Small Cell Lung Cancer、EGFR Sensitive Mutation
      • MCLA-129: 1500mg or 2000mg IV Q2W
      • Befotertinib: 75 mg or 100 mg Po QD
      • Bengbu, Anhui, China
      • +2 more
      Aug 28, 2023

      China With Non-Small-Cell Lung Cancer That is Unable to be

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
        • (no location specified)
        May 16, 2023

        Advanced NSCLC Trial in Jinan (almonertinib)

        Recruiting
        • Advanced Non-small Cell Lung Cancer
        • Jinan, Shandong, China
          Degan Lu
        Sep 12, 2023

        Non Small Cell Lung Cancer, Non-small Cell Carcinoma Trial in Belgium (Physical activity tele coaching program)

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • Non-small Cell Carcinoma
        • Physical activity tele coaching program
        • Genk, Limburg, Belgium
        • +5 more
        Sep 28, 2023

        HER3 Expression in Non-Small Cell Lung Cancer

        Recruiting
        • Non-small Cell Lung Cancer
        • Archival tissue specimen and immunohistochemistry staining
        • Miami, Florida
        • +1 more
        Mar 14, 2023

        Early Stage NSCLC, NSCLC Trial in Saint Louis (Computed tomography-guided stereotactic adaptive radiotherapy, ETHOS)

        Not yet recruiting
        • Early Stage Non-small Cell Lung Cancer
        • Non-small Cell Lung Cancer
        • Computed tomography-guided stereotactic adaptive radiotherapy
        • ETHOS
        • Saint Louis, Missouri
          Washington University School of Medicine
        Mar 14, 2023